HIV 1 News and Research

RSS

Report estimates human impact of cuts to U.S. global health spending over next five years

"Thousands of lives and years of gains made against HIV/AIDS, tuberculosis (TB) and malaria could be lost if proportional reductions are made to achieve the $1.2 trillion in spending reductions required by the Budget Control Act of 2011," according to a report issued on Monday by the Foundation for AIDS Research (amfAR), the Center for Global Health Policy's "Science Speaks" blog reports.

19 Oct 2011

Roundup: Mass. contemplates 'global payments'; rural hospitals struggling; Oregon liability cost studied

Although important details remain to be negotiated, the legislative leaders and Gov. Deval Patrick, all Democrats, are working toward a plan that would encourage flat "global payments" to networks of providers for keeping patients well, replacing the fee-for-service system that creates incentives for excessive care by paying for each visit and procedure.

19 Oct 2011

NanoViricides President completes stock sales program

NanoViricides, Inc. announced that its President, Dr. Anil Diwan, has completed the programmed sale of the NanoViricides stock that he had obtained as a founder.

18 Oct 2011

Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

Johnson & Johnson today announced sales of $16.0 billion for the third quarter of 2011, an increase of 6.8% as compared to the third quarter of 2010. Operational results increased 2.6% and the positive impact of currency was 4.2%. Domestic sales declined 3.7%.

18 Oct 2011

BGU substance abuse expert wins U.S. National Distinguished International Scientist Award

Prof. Richard Isralowitz, of Israel's Ben-Gurion University of the Negev (BGU), recently received the U.S. National Distinguished International Scientist Award for his work as director of the Regional Alcohol and Drug Abuse Resources (RADAR) Center.

18 Oct 2011

Rep. Lee asks Obama to take leadership role in fight against HIV/AIDS

According to the Center for Global Health Policy's "Science Speaks" blog, Rep. Barbara Lee (D-Calif.) on Thursday sent a letter to President Barack Obama asking for "his leadership in launching a renewed global effort to end the AIDS pandemic on World AIDS Day, December 1."

18 Oct 2011

Globe and Mail reports on death of Zambian HIV/AIDS advocate Winstone Zulu

Toronto's Globe and Mail reports on the death on Thursday of Winstone Zulu, an HIV/AIDS advocate from Zambia who lived with the virus for two decades. "His death has devastated the international community of AIDS activists," the newspaper writes.

18 Oct 2011

New research on link between APOL1 gene variants and kidney disease in African Americans

Compared to European Americans, African Americans are four to five times more likely to develop kidney failure. Also, family members of African Americans with kidney failure have an increased risk of developing kidney failure, which suggests that genetics may play a role in this skewed risk between races.

15 Oct 2011

Forum focuses on challenges facing women, girls affected by HIV in Eastern Europe, Central Asia

"Women, girls and HIV were the focus of a panel discussion on the final day of the International Forum on Millennium Development Goal (MDG) 6 in Eastern Europe and Central Asia," UNAIDS reports.

15 Oct 2011

Health groups urge Secretary of U.S. Army to sustain funding for military HIV research program

"Speaking out against a potential $16 million cut in the Army's base research and development budget for HIV, leaders of the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA) sent a letter Thursday to the Secretary of the U.S. Army, John McHugh, making the case for sustaining the U.S. Military HIV Research Program (MHRP)," according to the Center for Global Health Policy's "Science Speaks" blog.

15 Oct 2011

Emergency grant to end U.S. AIDS drug crisis gets rejected

The Global Fund for AIDS, Tuberculosis and Malaria has notified the AIDS Healthcare Foundation (AHF) that an application it submitted on behalf of the United States for an emergency grant of $50 million to end the ongoing AIDS drug crisis in the U.S. is being rejected because, as one of the wealthiest nations in the world, "the United States is not eligible for funding from the Global Fund."

14 Oct 2011

USAID award supports study of SILCS diaphragm plus tenofovir gel on HIV, HSV

USAID awarded CONRAD a five year project with a $2 million ceiling to focus on testing the safety and effectiveness of the SILCS diaphragm, the one-size-fits-most contraceptive barrier, combined with tenofovir gel -- the only topical product proven to prevent the acquisition of HIV and Herpes Simplex Virus.

14 Oct 2011

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of a preclinical study demonstrating highly specific, functional correction of the alpha 1-antitrypsin (A1AT) gene defect in patient-derived induced pluripotent stem cells (iPSCs) using zinc finger nucleases.

14 Oct 2011

Merck announces results from ISENTRESS Phase III combination study on HIV-1

Merck, known as MSD outside the United States and Canada, today announced results of new exploratory pre-specified analyses from the ongoing STARTMRK Phase III study of its integrase inhibitor ISENTRESS (raltegravir) Tablets in combination therapy compared to efavirenz in combination therapy in previously untreated adult HIV-1-infected patients.

14 Oct 2011

Insight into how powerful anti-HIV antibody grabs hold of the virus

Researchers at The Scripps Research Institute have uncovered the surprising details of how a powerful anti-HIV antibody grabs hold of the virus. The findings, published in Science Express on October 13, 2011, highlight a major vulnerability of HIV and suggest a new target for vaccine development.

14 Oct 2011

Dual drug sneaks across the blood-brain barrier to fight HIV

In an advance toward eliminating pockets of infection in the brain that help make HIV disease incurable, scientists report the development of new substances that first plug the biological vacuum cleaner that prevents anti-HIV drugs from reaching the brain and then revert to an active drug to treat HIV.

14 Oct 2011

InnaVirVax announces Phase I/IIa clinical trial authorization for its VAC-3S HIV vaccine

InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax’s activities.

14 Oct 2011

Viewpoints: 'Moneyball' and health care; Daschle on diabetes treatment; Elton John and Sen. Nelson on paying for AIDS drugs

Billy Beane's data-driven strategies made him the talk of baseball, the king of the current box office and a highly visible advocate for evidence-based medicine. But Beane's teams have faded since their "Moneyball" heyday -; and evidence-based medicine might not be the home run that some reformers hope it will be.

14 Oct 2011

Mental health services are 'critical' to comprehensive approach for people living with HIV

In this post in USAID's "IMPACTblog," Melissa Sharer, AIDSTAR-One senior care and support officer at John Snow, Inc., writes, "Although treatment is now widely available and people living with HIV (PLHIV) are able to live normal and active lives for many years, their mental health needs are often overlooked in care, treatment, and support programs." Sharer highlights the success of programs in Vietnam and in Uganda that "combine mental health and existing health services."

13 Oct 2011

U.S. Ambassador advises Kenya to seek additional sources of funding for health programs

"U.S. Ambassador Jonathan Gration has advised Kenya to seek new sources of money to finance health programs," Kenya's the Star reports, adding, "Gration said projects initiated by donors will only be sustainable if the Kenyan government takes over."

13 Oct 2011

HIV 1 News and Research

Report estimates human impact of cuts to U.S. global health spending over next five years

Roundup: Mass. contemplates 'global payments'; rural hospitals struggling; Oregon liability cost studied

NanoViricides President completes stock sales program

Johnson & Johnson third quarter sales increase 6.8% to $16.0 billion

BGU substance abuse expert wins U.S. National Distinguished International Scientist Award

Rep. Lee asks Obama to take leadership role in fight against HIV/AIDS

Globe and Mail reports on death of Zambian HIV/AIDS advocate Winstone Zulu

New research on link between APOL1 gene variants and kidney disease in African Americans

Forum focuses on challenges facing women, girls affected by HIV in Eastern Europe, Central Asia

Health groups urge Secretary of U.S. Army to sustain funding for military HIV research program

Emergency grant to end U.S. AIDS drug crisis gets rejected

USAID award supports study of SILCS diaphragm plus tenofovir gel on HIV, HSV

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Merck announces results from ISENTRESS Phase III combination study on HIV-1

Insight into how powerful anti-HIV antibody grabs hold of the virus

Dual drug sneaks across the blood-brain barrier to fight HIV

InnaVirVax announces Phase I/IIa clinical trial authorization for its VAC-3S HIV vaccine

Viewpoints: 'Moneyball' and health care; Daschle on diabetes treatment; Elton John and Sen. Nelson on paying for AIDS drugs

Mental health services are 'critical' to comprehensive approach for people living with HIV

U.S. Ambassador advises Kenya to seek additional sources of funding for health programs

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News